Prevention and control of influenza: Part I, Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

These recommendations update information on the vaccine available for controlling influenza during the 1994-95 influenza season. The recommendations supersede MMWR 1993;42(No. RR-6)1-13. Antiviral agents also have an important role in the control of influenza. Recommendations for the use of antiviral agents will be published later in 1994 as Part II of these recommendations.

[1]  P. Lane.  Sickle cell disease. , 1996, Pediatric clinics of North America.

[2]  G. Dinant,et al.  Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. , 1993, BMJ.

[3]  W. Aberer.  Vaccination despite thimerosal sensitivity , 1991, Contact dermatitis.

[4]  K. Nichol,et al.  Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial. , 1990, JAMA.

[5]  K. Nichol,et al.  Achieving the national health objective for influenza immunization: success of an institution-wide vaccination program. , 1990, The American journal of medicine.

[6]  J. Mills,et al.  Influenza in patients with human immunodeficiency virus infection. , 1990, Chest.

[7]  R. Couch,et al.  Live attenuated and inactivated influenza vaccine in school-age children. , 1990, American journal of diseases of children.

[8]  Update: influenza activity--worldwide and recommendations for influenza vaccine composition for the 1990-91 influenza season. , 1990, MMWR. Morbidity and mortality weekly report.

[9]  K. Nichol,et al.  Frequency of adverse reactions after influenza vaccination. , 1990, The American journal of medicine.

[10]  R. Krug,et al.  The Influenza Viruses , 2011, The Viruses.

[11]  W. Beyer,et al.  Antibody induction by influenza vaccines in the elderly: a review of the literature. , 1989, Vaccine.

[12]  J. Margolick,et al.  The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine. , 1989, JAMA.

[13]  S. Weingarten,et al.  Barriers to influenza vaccine acceptance. A survey of physicians and nurses. , 1989, American journal of infection control.

[14]  Henry Nider,et al.  Report of the Committee on Infectious Diseases , 1989 .

[15]  J. Thurn,et al.  Influenza A pneumonitis in a patient infected with the human immunodeficiency virus (HIV). , 1989, Chest.

[16]  J. Lentino,et al.  Influenza A among hospital personnel and patients. Implications for recognition, prevention, and control. , 1989, Archives of internal medicine.

[17]  Influenza vaccination levels in selected states--Behavioral Risk Factor Surveillance System, 1987. , 1989, MMWR. Morbidity and mortality weekly report.

[18]  S. Hewitt,et al.  General recommendations on immunization. , 1989, MMWR. Morbidity and mortality weekly report.

[19]  K. Margolis,et al.  Organizational strategies to improve influenza vaccine delivery. A standing order in a general medicine clinic. , 1988, Archives of internal medicine.

[20]  B. Polk,et al.  The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines. , 1988, Annals of internal medicine.

[21]  A. Kendal,et al.  Immunization policies and vaccine coverage among adults. The risk for missed opportunities. , 1988, Annals of internal medicine.

[22]  S. Wallenstein,et al.  Association of influenza immunization with reduction in mortality in an elderly population. A prospective study. , 1988, Archives of internal medicine.

[23]  J. Herndon,et al.  Assessing trends in mortality in 121 U.S. cities, 1970-79, from all causes and from pneumonia and influenza. , 1988, Public health reports.

[24]  Acute respiratory illness among cruise-ship passengers--Asia. , 1988, MMWR. Morbidity and mortality weekly report.

[25]  M. Drummond,et al.  The costs and benefits of preventing influenza in Ontario's elderly. , 1988, Canadian journal of public health = Revue canadienne de sante publique.

[26]  T. W. Austin.  Prevention and Control of Nosocomial Infections. , 1987 .

[27]  R. Douglas,et al.  Immunization of elderly people with two doses of influenza vaccine , 1987, Journal of clinical microbiology.

[28]  A. Kendal,et al.  Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. , 1987, American journal of public health.

[29]  L. Kingsley,et al.  Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. , 1987, JAMA.

[30]  K. Herrmann.  Options for the control of influenza , 1986 .

[31]  W. Barker,et al.  Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. , 1986, American journal of public health.

[32]  R. Couch,et al.  Influenza: its control in persons and populations. , 1986, The Journal of infectious diseases.

[33]  J. Mullooly,et al.  Risk of acute respiratory disease among pregnant women during influenza A epidemics. , 1986, Public health reports.

[34]  A. Kendal,et al.  Options for the control of influenza , 1986 .

[35]  S B Thacker,et al.  The persistence of influenza A in human populations. , 1986, Epidemiologic reviews.

[36]  D M Perrotta,et al.  Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza. , 1985, American journal of epidemiology.

[37]  R. Strunk,et al.  Safe administration of influenza vaccine in asthmatic children hypersensitive to egg proteins. , 1985, The Journal of pediatrics.

[38]  A. Kendal,et al.  Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. , 1985, JAMA.

[39]  W. P. Glezen,et al.  Trivalent, inactivated influenza virus vaccine in children with sickle cell disease. , 1983, American journal of diseases of children.

[40]  B. Bean,et al.  Influenza B: hospital activity during a community epidemic. , 1983, Diagnostic microbiology and infectious disease.

[41]  A. Monto,et al.  Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children--a multicentered evaluation of dosage and safety. , 1983, Reviews of infectious diseases.

[42]  R. Schooley,et al.  Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines. , 1983, Reviews of infectious diseases.

[43]  J. L. Montagne,et al.  Summary of clinical trials of inactivated influenza vaccine - 1978. , 1983, Reviews of infectious diseases.

[44]  R. Couch,et al.  Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines - 1978. , 1983, Reviews of infectious diseases.

[45]  H. Kessler,et al.  A hospital-based influenza immunization program, 1977-78. , 1983, American journal of public health.

[46]  L. Schonberger,et al.  Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination. , 1982, JAMA.

[47]  R. Goodman,et al.  Simultaneous Administration of Influenza and Pneumococcal Vaccines , 1982 .

[48]  W. P. Glezen,et al.  Serious morbidity and mortality associated with influenza epidemics. , 1982, Epidemiologic reviews.

[49]  J. Mullooly,et al.  Pneumonia and influenza deaths during epidemics: implications for prevention. , 1982, Archives of internal medicine.

[50]  W. Dowdle.  INFLUENZA IMMUNOPROPHYLAXIS AFTER 30 YEARS' EXPERIENCE , 1981 .

[51]  J. Mullooly,et al.  Impact of epidemic type A influenza in a defined adult population. , 1980, American journal of epidemiology.

[52]  W. Pierson,et al.  Safety of influenza vaccination in allergic children. , 1977, The Journal of infectious diseases.

[53]  Rspm μgm.  Methods , 1972 .